ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

Item
http://www.wikidata.org/entity/Q37030917
Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial.Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy.The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram dataLong-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial.Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma.Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cellsTranslational molecular imaging in exocrine pancreatic cancer
P2860

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

Item
http://www.wikidata.org/entity/Q37030917
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@en
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@nl
type
label
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@en
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@nl
prefLabel
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@en
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
ARCII: A phase II trial of the ...... inoperable pancreatic cancer.
@en
P2093
P2860
P304
P31
P356
10.1016/J.RADONC.2016.03.021
P433
P478
P50
P577
P698
P921
P932